期刊文献+

药物遗传学在法医学中的应用前景

The Prospect of Application of Toxicogenetics/Pharmcogenetics Theory and Methods in Forensic Practice
下载PDF
导出
摘要 人类因为基因的差异而表现出对某种药物、毒物、外界有害的化学物质、过敏原作出不同的反应。这种遗传背景的差异使一些人可以快速地清除这些物质,而另一些人却因此产生严重的不良反应,甚至死亡。药物遗传学和药物基因组学,通过对人类基因组测序和大规模基因组多态性的鉴别研究,诠释了个体遗传差异与对药物毒物不同反应之间的关系,这为该类案件的法医学鉴定提供了新的理论基础和研究手段。 Individual response to drugs, toxicants, environmental chemicals and allergens varies with genotype. Some respond well to these substances without significant consequences, while others may respond strongly with severe consequences and even death. Toxicogenetics and toxicogenomics as well as pharmacogenetics explain the genetic basis for the variations of individual response to toxicants by sequencing the human genome and large-scale identification of genome polymorphism. The new disciplines will provide a new route for forensic specialists to determine the cause of death.
出处 《法医学杂志》 CAS CSCD 2007年第5期362-364,共3页 Journal of Forensic Medicine
关键词 药物遗传学 基因多态性 单核苷酸多态性图谱 法医学 pharmacogenetics gene polymorphism SNP mapping forensic medicine
  • 相关文献

参考文献19

  • 1Susanne B. Haga,Wylie Burke, MD,崔艳丽(译),赵秀丽(校).利用药物遗传学提高药物的安全性和有效性[J].美国医学会杂志(中文版),2005,24(4):230-232. 被引量:1
  • 2刘永学.药物遗传学在评价药物安全性和降低药物副作用中的作用[J].国外医学(药学分册),2001,28(4):197-200. 被引量:2
  • 3Kupiec TC,Raj V,Vu N.Pharmacogenomics for the forensic toxicologist[J].J Anal Toxicol,2006,30(2):65-72.
  • 4Lai E,Riley J,Purvis I,et al.A 4-Mb high-density single nucleotide polymorphism-based map around human APOE[J].Genomics,1998,54:31-38.
  • 5Rioux JD,Daly MJ,Silverberg MS,et al.Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease[J].Nat Genet,2001,29:223-228.
  • 6Hetherington S,Hughes A,Mosteller M,et al.Genetic variations in the HLA-B region and hypemensitivity reactions to abacavir[J].Lancet,2002,359:1121-1122.
  • 7Jannetto PJ,Wong SH,Gock SB,et al.Pharmacogenomics as molecular autopsy for postmortem forensic toxicology:genotyping cytochrome P450 2D6 for oxycodone eases[J].J Anal ToxicoI,2002,26(7):438--447.
  • 8Jin M,Cock SB,Jannetto PJ,et al.Pharmacogenomics as molecular autopsy for forensic toxicology:genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases[J].J Anal Toxicol,2005,29(7):590-598.
  • 9Koski A,Sistonen J,Ojanper I,et al.CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies[J].Forensic Sci Int,2006,158(2-31:177-183.
  • 10张松,董兆文.从药物遗传学到药物基因组学[J].中国优生与遗传杂志,2001,9(2):1-2. 被引量:2

二级参考文献31

  • 1Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
  • 2Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-1205.
  • 3Bates DW, Spell N, Cullen D J, et al. The cost of adverse drug events in hospitalized patients. JAMA. 1997;277:307-311.
  • 4Barnes P J, Woolcock AJ. Difficult asthma. Eur Respir J. 1998;12:1209-1218.
  • 5Mackenzie IS, Brown MJ. Genetic profiling versus drug rotation in the optimisation of antihypertensive treatment. Clin Med. 2002;2:465-473.
  • 6Regaldo A. Inventing the pharmacogenomics business. Am J Health Syst Pharm.1999;56:40-50.
  • 7Lindpainter K. PharmacogeneUcsand pharmacogenomicsin drug discovery and development: an overview. Cl in Chem Lab Med. 2003;41:398-410.
  • 8Oscarson M. Pharmacogenetics of drug metabolizing enzymes: importancefor personalized medicine. Clin Chem Lab Med. 2003;41:573-580.
  • 9Evans WE, McLeod HL. Pharrnacogenomics-drug disposition, drug targets,and side effects; N Engl J Med. 2003;348:538-549.
  • 10Krynetski EY, Evans WE. Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm. Phafm Res. 1999;16:342-349.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部